Home / Tag Archives: avelumab

Tag Archives: avelumab

Avelumab safety profile is “acceptable”

Avelumab bavencio dermatology

Although avelumab has changed the treatment landscape, much more needs to be learned about the role of immune checkpoint inhibitors in treatment of Merkel cell carcinoma (MCC), said Mahtab Samimi, M.D., Ph.D., here at the 26th European Academy of Dermatology and Venereology (EADV) Congress in Geneva. The benefit of avelumab (Bavencio, EMD Serono, Inc.) is …

Read More »